Hledání v detailu akcií
Moje portfolio
Nastavit Oblíbené, nastavit Portfolio
Oblíbené tituly
select
NázevNejlepší
nákup
Nejlepší
prodej
Změna
(%)
ČEZ0,00
KB0,00
PKN65,1165,142,13
Msft-0,17
Nokia3,29053,2965-1,02
IBM0,08
Mercedes-Benz Group AG73,8573,870,39
PFE-0,11
29.03.2024 1:04:00
Indexy online
AD Index online
select
AD Index online
 

  • 11.03.2024 16:30:24
Evotec Depository Receipt (EVTGy.F, Frankfurt)
Závěr k 28.3.2024 Změna (%) Změna (EUR) Objem obchodů (EUR)
7,20 5,88 0,40 163
R - Real-Time data si mohou aktivovat klienti Patria Plus / Investor Plus ZDE.

 
  • Poslední aktualizace: 29.03.2024
Popis společnosti
Obecné informace
Název společnostiEvotec SE (ADR)
TickerEVO
Kmenové akcie:ADR
RICEVO.O
ISIN-
Poslední známé roční výsledky31.12.2022
Počet zaměstnanců k 31.12.2022 0
Akcie v oběhu k 31.01.2023 176 935 821
MěnaEUR
Kontaktní informace
UliceEssener Bogen 7
MěstoHAMBURG
PSČ22419
ZeměGermany
Kontatní osoba 
Funkce kontaktní osoby 
Telefon4 940 560 810
Fax494056081222

Business Summary: Evotec SE is a Germany-based drug discovery and development company. The company is engaged in development of new pharmaceutical products through research alliances and development partnerships with pharmaceutical and biotechnology companies, academic institutions, patient organizations and venture capital companies. The drug discovery solutions are provided in the form of fee-for-service work, integrated drug discovery alliances, development partnerships, licensing of drug candidates and consulting arrangements. Evotec SE operates in a number of areas, including neuroscience, diabetes and complications of diabetes, pain and inflammation, oncology, infectious diseases, respiratory diseases and fibrosis. Its pipeline covers a range of therapeutic areas, such as CNS Insomnia, Chronic cough, immunology & inflammation, women’s health endometriosis, nephrology, dermatological diseases, fibrotic disease and antiviral, among others.
Financial Summary: BRIEF: Evotec SE (ADR) has not disclosed any comparable financial information.
Odvětvová klasifikace
TRBC2009Biotechnology / Medical Research
TRBC2012Biotechnology & Medical Research (NEC)
RBSS2004Biotechnology
MGINDUSTRYBiotechnology & Drugs
MGSECTORHealthcare
NAICSResearch and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
NAICSPharmaceutical Preparation Manufacturing
NAICS2007Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
NAICS2007Pharmaceutical Preparation Mfg
NAICS1997Research and Development in the Physical, Engineering, and Life Sciences
NAICS1997Pharmaceutical Preparation Manufacturing
SICPharmaceutical Preparations
SICCommercial Physical Research
SICPharmaceutical Preparations



  • Poslední aktualizace: 29.03.2024
Management společnosti
FunkceJménoVěkVe funkci odVe firmě od
Independent Chairwoman of the Supervisory BoardIris Loew-Friedrich6315.06.202119.06.2019
Independent Vice Chairman of the Supervisory BoardRoland Sackers5415.06.202115.06.2021
Chief Financial Officer, Member of the Management BoardLaetitia Rouxel4901.04.202301.04.2023
Chief Operating Officer, Member of the Management BoardCraig Johnstone5301.01.201901.01.2019
Chief Scientific Officer, Member of the Management BoardCord Dohrmann5801.09.201001.09.2010
Member of the Management Board, Chief Business OfficerMatthias Evers4901.05.202201.05.2022